Squamous Histology Transitional and Papillary Histology Other Histologies
  Renal Pelvis Ureter Both Sites Renal Pelvis Ureter Both Sites Renal Pelvis Ureter Both Sites
Gender Men Women 56 (46.3%) 65 (53.7%) 42 (53.9%) 36 (46.1%) 98 (49.3%) 101 (50.7%) 4396 (60.4%) 2883 (39.6%) 3377 (66.0%) 1739 (34.0%) 7,773 (62.7%) 4,622 (37.3%) 190 (60.1%) 126 (39.9%) 192 (63.3%) 111 (36.6%) 382 (61.7%) 237 (38.3%)
Race Caucasian Blacks Hispanics Asian/Other 102 (84.3%) 7 (5.8%) 3 (2.5%) 9 (7.4%) 62 (79.5%) 5 (6.4%) 4 (5.1%) 7 (8.9%) 164 (82.4%) 12 (6.0%) 7 (3.5%) 16 (8.1%) 6376 (87.6%) 308 (4.2%) 200 (2.8%) 395 (5.4%) 4574 (89.4%) 131 (2.6%) 117 (2.3%) 294 (5.8%) 10,950 (88.3%) 439 (3.5%) 317 (2.6%) 689 (5.6%) 260 (82.3) 24 (7.6%) 16 (5.0%) 16 (5.0%) 264 (87.1%) 19 (6.3%) 5 (1.7%) 15 (5.0%) 524 (84.6%) 43 (7.0%) 21 (3.4%) 31 (5.0%)
Age Group 30-49 years old 50-74 years old >75 years old 11 (9.1%) 60 (49.6%) 50 (41.3%) 4 (5.1%) 51 (65.4%) 23 (29.5%) 15 (7.5%) 111 (55.8%) 73 (36.7%) 438 (6.0%) 4199 (57.7%) 2642 (36.3%) 166 (3.2%) 2945 (57.6) 2005 (39.2%) 604 (4.9%) 7,144 (57.6%) 4,647 (37.5%) 42 (13.3%) 174 (55.0%) 100 (31.7%) 17 (5.6%) 155 (51.2%) 131 (43.23%) 59 (9.5%) 329 (53.2%) 231 (37.3%)
Decade of diagnosis 1973-1979 1980-1989 1990-1999 2000-2004 35 (28.9%) 39 (32.2%) 34 (28.1%) 13 (10.7%) 16 (20.5%) 30 (38.5%) 21 (26.9%) 11 (14.1%) 51 (25.6%) 69 (34.7%) 55 (27.6%) 24 (12.1%) 1251 (17.2%) 2142 (29.4%) 2524 (34.7%) 1362 (18.7%) 751 (14.7%) 1486 (29.0%) 1836 (35.9%) 1043 (20.4%) 2,002 (16.2%) 3,628 (29.3%) 4,360 (35.2%) 2,405 (19.4%) 82 (25.9%) 92 (29.1%) 96 (30.4%) 46 (14.6%) 53 (17.5%) 103 (34.0%) 95 (31.4%) 52 (177.2%) 135 (21.8%) 195 (31.5%) 191 (30.9%) 98 (15.8%)
Stage In situ Local Regional *-LN+ *-LN- *-Not available Distal Insuff. Inform. 1 (0.8%) 14 (11.6%) 56 (46.3%) 5(8.9%) 4(7.1%) 47 (83.9%) 40 (33.1%) 10 (8.3%) 3 (3.9%) 15 (19.2%) 44 (56.4%) 2(4.5%) 1(2.3%) 93.2%) 13 (16.7%) 3 (3.9%) 4 (2.0%) 29 (14.6%) 100 (50.3%) 7(7.0%) 5(5.0%) 88(88.0%) 53 (26.6%) 13 (6.5%) 1158 (15.9%) 2502 (34.4%) 2666 (36.6%) 195(7.3%) 222(8.3%) 2,249(84.4%) 650 (8.9%) 303 (4.2%) 1261 (24.7%) 1757 (34.3%) 1606 (31.4%) 89(5.5%) 142(8.8%) 1,375(85.6%) 260 (5.0%) 232 (4.5%) 2,419 (19.5%) 4,259 (34.4%) 4,272 (34.5%) 284(6.7%) 364(8.5%) 3,624(84.8%) 910 (7.3%) 535 (4.3%) 16 (5.0%) 85 (26.9%) 78 (24.7%) 10(12.8%) 9(11.5%) 59(75.6%) 82 (26.0%) 55 (17.4%) 102 (33.7%) 39 (12.9%) 49 (16.2%) 3(6.1%) 2(4.1%) 44(89.8% 37 (12.2%) 76 (25.1%) 118 (19.1%) 124 (20.0%) 127 (20.5%) 13(10.2%) 11(8.7%) 103(81.1%) 119 (19.2%) 131 (21.2%)
Surgery Yes No 94 (77.7%) 27 (22.3%) 62 (79.5%) 16 (20.5%) 156 (78.4%) 43 (21.6%) 6561 (90.1%) 718 (9.9%) 4622 (90.3%) 494 (9.7%) 11,183 (90.2%) 1,212 (9.8%) 188 (59.5%) 128 (40.5%) 181 (59.7%) 122 (40.3%) 369 (59.6%) 250 (40.4%)
Radiation Yes No 19 (15.70%) 102 (84.30%) 24 (30.77%) 54 (69.23%) 43 (21.6%) 156 (78.4%) 425 (5.8%) 6854 (94.2%) 357 (7.0%) 4759 (93.0%) 782 (6.3%) 11,613 (93.7%) 39 (12.3%) 277 (87.7%) 33 (10.9%) 270 (89.1%) 72 (11.6%) 547 (88.4%)
*The percentage figure refers to the total amount of cases in the regional disease category. The table above displays the distribution of clinically relevant disease characteristics for patients with UUT malignancies across the different histologies, i.e. transitional cell, squamous cell and others( mainly small cell, sarcomatoid and undifferentiated carcinomas).
Table 2: